| Persistence, dose titration, and health care resource utilization among Crohn’s disease patients treated with ustekinumab: a real-world analysis in the United States C Obando, Z Ding, E Muser, N Vaidya, W Qiang, X Sun, H Wang, ... Advances in Therapy 37, 2127-2143, 2020 | 28 | 2020 |
| Comorbidity and economic burden among moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population S Lee, L Xie, Y Wang, N Vaidya, O Baser Journal of medical economics 21 (6), 564-570, 2018 | 19 | 2018 |
| Evaluating the effect of treatment persistence on the economic burden of moderate to severe psoriasis and/or psoriatic arthritis patients in the US department of defense population S Lee, L Xie, Y Wang, N Vaidya, O Baser Journal of Managed Care & Specialty Pharmacy 24 (7), 654-663, 2018 | 17 | 2018 |
| Patients with idiopathic membranous nephropathy: a real-world clinical and economic analysis of US claims data TA Nazareth, F Kariburyo, A Kirkemo, L Xie, A Pavlova-Wolf, ... Journal of Managed Care & Specialty Pharmacy 25 (9), 1011-1020, 2019 | 14 | 2019 |
| Hypoglycaemia and treatment patterns among insulin‐treated patients with type 2 diabetes who switched to insulin glargine 300 units/mL versus other basal insulin in a real … FL Zhou, C Nicholls, L Xie, Y Wang, N Vaidya, LF Meneghini Endocrinology, Diabetes & Metabolism 2 (3), e00073, 2019 | 7 | 2019 |
| Relationship between treatment persistence and A1C trends among patients with type 2 diabetes newly initiating basal insulin FL Zhou, L Xie, C Pan, Y Wang, N Vaidya, F Ye, R Preblick, L Meneghini Diabetes, Obesity and Metabolism 20 (5), 1298-1301, 2018 | 7 | 2018 |
| A cost-effectiveness analysis of pre-exposure prophylaxis for HIV: A us payer perspective N Vaidya, JD Campbell Value in Health 18 (3), A236-A237, 2015 | 2 | 2015 |
| Impact of assisted reproductive therapy (ART) on infant health and health care cost outcomes DC Tabano, A Schroeder, K Sullivan, N Vaidya Value in Health 17 (7), A520, 2014 | 2 | 2014 |
| Mo1779-Evaluate the Treatment Patterns and Healthcare Utilizations for Biologic Therapies for Crohn's Disease C Obando, L Xie, N Vaidya, J Sah Gastroenterology 154 (6), S-799, 2018 | 1 | 2018 |
| PATIENTS WITH NEPHROTIC SYNDROME (NS) RECEIVING REPOSITORY CORTICOTROPIN INJECTION (RCI) OR RITUXIMAB (RTX): REAL-WORLD (RW) EVIDENCE FROM A US CLAIMS ANALYSIS T Nazareth, F Kariburyo, A Pirani, A Kirkemo, L Xie, N Vaidya, M Philbin AMERICAN JOURNAL OF KIDNEY DISEASES 69 (4), A69-A69, 2017 | 1 | 2017 |
| Evaluating The Economic Burden and Health Care Utilization Of Breast Cancer in The Us Medicare Population L Xie, N Vaidya, K Xin, MF Kariburyo, H Yuce, O Baser Value in Health 19 (7), A726-A727, 2016 | 1 | 2016 |
| A Health Technology Assessment of a Proposed Biosimilar for the Treatment of Chemotherapy Induced Febrile Neutropenia: A United States Payer Perspective N Vaidya, L Cosler Value in Health 17 (3), A88, 2014 | 1 | 2014 |
| CO89 Reductions in Concomitant Medication Use and HbA1c Impact Following Initiation of an Advanced Hybrid Closed-Loop System (AHCL) Versus Multiple Daily Injection (MDI … BV Patel, J Manjelievskaia, SM Wang, N Vaidya, KW Mcdermott, S Wall, ... Value in Health 27 (12), S31, 2024 | | 2024 |
| EE125 Evaluating the Impact of Hybrid Closed-Loop Systems (HCLS) on Healthcare Utilization and Costs Compared to Standard of Care Therapy Among Patients with Type 1 Diabetes … J Manjelievskaia, N Vaidya, SM Wang, KW McDermott, K Lavelle, S Wall, ... Value in Health 27 (6), S80, 2024 | | 2024 |
| EE286 Post-Infusion Monitoring Costs By Site of Care Among Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) Who Received Second-LINE Treatment with … N McGarvey, N Vaidya, M Gitlin, A Lee, B Ung, T Carattini, SJ Keating Value in Health 25 (7), S389-S390, 2022 | | 2022 |
| Mo1909–Evaluation of Health Care Utilization, Hospitalization/Emergency Room Costs, and Other Medication Use Among Crohn’s Disease Patients Using Ustekinumab in Three Large … C Obando, Z Ding, E Muser, N Vaidya, W Qiang, X Sun, H Wang, ... Gastroenterology 156 (6), S-882, 2019 | | 2019 |
| EVALUATION OF USTEKINUMAB TREATMENT PATTERNS AMONG CROHN'S DISEASE PATIENTS IN THREE LARGE US COMMERCIAL CLAIMS DATABASES C Obando, Z Ding, E Muser, N Vaidya, W Qiang, X Sun, H Wang, ... Gastroenterology 156 (6), S882-S882, 2019 | | 2019 |
| Evaluating The Economic Burden And Health Care Utilization Of Bacterial Pneumonia In The US Department Of Defense Population N Vaidya, Y Wang, L Xie, O Baser Value in Health 20 (9), A644, 2017 | | 2017 |
| Impact of treatment persistence on glycated haemoglobin A (1c)(HbA (1c)) trends among patients with type 2 diabetes newly initiated on basal insulin L Xie, FL Zhou, C Pan, N Vaidya, F Ye, R Preblick, L Meneghini DIABETOLOGIA 60, S309-S309, 2017 | | 2017 |
| Evaluating the Economic Burden and Health Care Utilization of Migraine in the US Department of Defense Population N Vaidya, L Xie, Y Wang, J Du, O Baser PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26, 133-134, 2017 | | 2017 |
Onur BaserSchool of Public Health, City University of New York在 sph.cuny.edu 的电子邮件经过验证
